Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil

J Shi, L Wei - Journal of cardiovascular pharmacology, 2013 - journals.lww.com
Rho kinase (ROCK) is a major downstream effector of the small GTPase RhoA. ROCK
family, consisting of ROCK1 and ROCK2, plays central roles in the organization of actin …

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

E Hu, D Lee - Expert Opinion on Therapeutic Targets, 2005 - Taylor & Francis
Rho kinase (ROCK) belongs to a family of Ser/Thr protein kinases that are activated via
interaction with the small GTP-binding protein RhoA. Growing evidence suggests that RhoA …

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases

M Dong, BP Yan, JK Liao, YY Lam, GWK Yip… - Drug discovery today, 2010 - Elsevier
The Rho/rho-kinase (ROCK) pathway has an important role in the pathogenesis of several
cardiovascular diseases. The activation of ROCK is involved in the regulation of vascular …

ROCKs as therapeutic targets in cardiovascular diseases

Y Rikitake, JK Liao - Expert review of cardiovascular therapy, 2005 - Taylor & Francis
There is growing evidence that Rho-kinases (ROCKs), the immediate downstream targets of
the small guanosine triphosphate-binding protein Rho, may contribute to cardiovascular …

2015 ATVB Plenary Lecture: Translational Research on Rho-Kinase in Cardiovascular Medicine

H Shimokawa, K Satoh - Arteriosclerosis, thrombosis, and vascular …, 2015 - Am Heart Assoc
Rho-kinase (ROCKs) is an important downstream effector of the small GTP-binding protein
Ras homolog gene family member A. There are 2 isoforms of ROCK, ROCK1 and ROCK2 …

Development of Rho-kinase inhibitors for cardiovascular medicine

H Shimokawa, M Rashid - Trends in pharmacological sciences, 2007 - cell.com
Rho-kinase (ROCK) is one of the downstream effectors of the small G-protein Rho. The Rho–
ROCK pathway has an important role in mediating various cellular functions, including …

Rho-kinase: important new therapeutic target in cardiovascular diseases

K Satoh, Y Fukumoto… - American Journal of …, 2011 - journals.physiology.org
Rho-kinase (ROCKs) belongs to the family of serine/threonine kinases and is an important
downstream effector of the small GTP-binding protein RhoA. There are two isoforms of Rho …

Rho kinases and cardiac remodeling

T Shimizu, JK Liao - Circulation Journal, 2016 - jstage.jst.go.jp
Hypertensive cardiac remodeling is characterized by left ventricular hypertrophy and
interstitial fibrosis, which can lead to heart failure with preserved ejection fraction. The Rho …

Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm

M Dong, BP Yan, CM Yu - Cardiovascular & Hematological …, 2009 - ingentaconnect.com
Rho-kinase (ROCK) is one of the effectors of the small GTP-binding protein Rho.
Accumulating evidence suggests that the Rho/ROCK system may play an important role in …

Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.

E Hu, D Lee - Current Opinion in Investigational Drugs (London …, 2003 - europepmc.org
RhoA and Rho-kinase (ROCK) participate in diverse cellular signaling functions such as
smooth muscle contraction, cytoskeleton rearrangement, and cell migration and …